TPA
Trivium Point Advisory’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,465
| Closed | -$795K | – | 190 |
|
|
2022
Q2 | $795K | Buy |
3,465
+301
| +10% | +$69.1K | 0.24% | 124 |
|
|
2022
Q1 | $905K | Buy |
3,164
+533
| +20% | +$152K | 0.2% | 135 |
|
|
2021
Q4 | $991K | Sell |
2,631
-227
| -8% | -$85.5K | 0.21% | 127 |
|
|
2021
Q3 | $1.19M | Buy |
2,858
+164
| +6% | +$68.3K | 0.28% | 112 |
|
|
2021
Q2 | $997K | Buy |
2,694
+868
| +48% | +$321K | 0.25% | 122 |
|
|
2021
Q1 | $529K | Buy |
1,826
+334
| +22% | +$96.8K | 0.14% | 141 |
|
|
2020
Q4 | $393K | Buy |
1,492
+292
| +24% | +$76.9K | 0.11% | 151 |
|
|
2020
Q3 | $272K | Buy |
+1,200
| New | +$272K | 0.1% | 147 |
|